Table 1 Table showing the demographic details of the patient enrolled in the study
From: Bisphosphonate combination therapy for non-femoral avascular necrosis
S. No. | Age/sex | BMI | Side of affection | Dominant (D)/non-dominant (ND) | Site of affection | Stage at start of therapy | Last follow-up (months) | Stage at final follow-up |
|---|---|---|---|---|---|---|---|---|
1 | 64/M | 28.8 | Right | D | Humeral head | 2 | 45 | 3 |
2 | 50/F | 26.5 | Left | ND | Humeral head | 1 | 48 | 2 |
3 | 18/M | 20.8 | Right | D | Humeral head | 2 | 25 | 3 |
4 | 18/M | 21.6 | Left | ND | Humeral head | 2 | 25 | 2 |
5 | 30/M | 19.6 | Left | ND | Humeral head | 2 | 14 | 3 |
6 | 47/M | 32.4 | Right | - | Talus | 2 | 52 | 2 |
7 | 65/F | 26.7 | Right | - | Talus | 2 | 44 | 3 |
8 | 66/M | 35.6 | Right | - | Talus | 1 | 56 | 3 |
9 | 50/M | 33.2 | Left | - | Talus | 2 | 50 | 2 |
10 | 23/M | 21.4 | Right | D | Scaphoid | 2 | 32 | 2 |
11 | 32/M | 31.9 | Left | ND | Scaphoid | 2 | 25 | 2 |
12 | 52/F | 20.6 | Left | ND | Lunate | 2 | 26 | 2 |
13 | 30/M | 16.8 | Right | D | Lunate | 2 | 14 | 3 |
14 | 23/F | 21.3 | Right | D | Lunate | 1 | 48 | 2 |
15 | 25/F | 23.6 | Right | - | Proximal tibia | 1 | 46 | 2 |
16 | 42/M | 19.4 | Right | - | Proximal tibia | 1 | 24 | 1 |
17 | 27/F | 28.8 | Left | - | Metatarsal head | 1 | 36 | 2 |
18 | 32/M | 31.2 | Right | - | Metatarsal head | 1 | 26 | 1 |